This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rite Aid Reports 1.1 Percent Same Store Sales Decrease For October

Rite Aid Corporation (NYSE: RAD) today announced sales results for October.

Monthly Sales

For the four weeks ended Oct. 27, 2012, same store sales decreased 1.1 percent over the prior-year period. October front-end same store sales increased 1.5 percent. Pharmacy same store sales, which included an approximate 971 basis points negative impact from new generic introductions, decreased 2.3 percent. Prescription count at comparable stores increased 4.7 percent over the prior-year period.

Total drugstore sales for the four-week period decreased 1.8 percent to $1.918 billion compared to $1.954 billion for the same period last year. Prescription sales accounted for 68.2 percent of drugstore sales, and third party prescription sales represented 96.5 percent of pharmacy sales.

Hurricane Sandy Impact

The Company estimates that approximately 1.1 percent of October’s front-end same store sales increase of 1.5 percent and approximately 0.2 percent of October’s 4.7 percent prescription count at comparable stores increase was attributable to pre-storm sales associated with Hurricane Sandy.

It is anticipated that Hurricane Sandy will have a negative impact on same store sales results for the month of November, due to temporary store closures resulting from the hurricane. As of the close of business on October 31, Rite Aid had 188 stores either closed or operating with no power, down from a peak of 790 closed during the height of the storm on Monday evening, October 29. As of October 31, the company has eight stores that have sustained substantial damage, although this number could increase as Rite Aid field leaders gain access to more locations. The Company is re-opening the affected stores as quickly as possible.

Year-to-Date Sales

Same store sales for the 34-week period ended Oct. 27, 2012 increased 0.7 percent over the prior-year period. Front-end same store sales increased 2.1 percent while pharmacy same store sales increased 0.1 percent. Prescription count at comparable stores increased 3.7 percent over the prior-year period.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs